← Eichor
Condition: Cardioprotection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cardioprotection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation
Phase 2 · 1 location(s) · Research Institute of Geroprotective Technologies · NCT07397351Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction
NA · 9 location(s) · Harbin Medical University · NCT04912518Cardioprotection in AML
Phase 2 · 1 location(s) · University of Virginia · NCT04977180Exercise Preconditioning to Protect Against Dialysis-induced Cardiac Injury
NA · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT06735378Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients
NA · 2 location(s) · University of Avignon · NCT07269379Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NA · 14 location(s) · Fundación Instituto de Estudios de Ciencias de la Salud de C · NCT03711110Paced Heart Rate Acceleration for Cardiac Conditioning
NA · 1 location(s) · Denice Hodgson-Zingman, MD · NCT06332391CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
Phase 3 · 3 location(s) · 4th Military Clinical Hospital with Polyclinic, Poland · NCT06304857Remote Ischaemic Conditioning in STEMI Patients in AFRICA
NA · 20 location(s) · University of Cape Town · NCT04813159Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
Phase 2 · 7 location(s) · Nyrada Pty Ltd · NCT07362446Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)
NA · 1 location(s) · Baker Heart and Diabetes Institute · NCT04983823Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03589729Cardioprotection on Chemotherapy-Induced Cardiotoxicity
Phase 3 · 2 location(s) · Ain Shams University · NCT06853951Trans-coronary Cooling and Dilution for Cardioprotection During Revascularisation for ST-elevation Myocardial Infarction
NA · 1 location(s) · Royal Brompton & Harefield NHS Foundation Trust · NCT06128993Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Phase 4 · 4 location(s) · Silesian Centre for Heart Diseases · NCT05465031Remote Ischemic Preconditioning in Type 2 Diabetic Patients Undergoing CABG
NA · 2 location(s) · Muğla Sıtkı Koçman University · NCT06977230
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.